/

Copy.ai

REWARD45% recurring · 12 months
COOKIE60 days
LISTED BY@hidrix · 3d ago

AI-powered marketing copy and sales workflow platform. Started as an AI copywriting tool and evolved into a GTM (go-to-market) AI workflow platform for sales and marketing teams. Used by 15M+ users.

Why Promote Copy.ai?

  • 20% recurring commission — competitive rate on plans starting at $49/month for teams.
  • Brand recognition — one of the earliest and most well-known AI writing tools. The name alone carries trust.
  • Enterprise pivot — shifted from individual writers to team/enterprise workflows, meaning higher contract values.

Commission Details

DetailValue
Commission20% recurring
Duration12 months
Cookie30 days
NetworkDirect (Copy.ai)
PaymentMonthly
Min. payout$50

Who Converts?

  • Sales teams — AI-powered prospecting, email sequences, and outreach personalization at scale.
  • Marketing teams — blog posts, social media copy, ad variations, and product descriptions generated in bulk.
  • Agencies — manage multiple client accounts with team collaboration features.

Earning Potential

Based on Pro at $49/month and Team custom pricing:

  • 10 Pro referrals/month = $98/month recurring
  • Enterprise deals can be $1,000+/month — 20% of that is significant
  • Higher price point offsets lower volume

Easy to Sell Because

  1. Free tier available — 2,000 words/month free. Users can test the quality before committing.
  2. GTM workflow templates — pre-built workflows for specific sales and marketing tasks. Easy to demo specific use cases.
  3. Strong brand — "Copy.ai" is memorable and frequently appears in "best AI writing tools" roundups.

Heads Up

  • Identity crisis. The pivot from copywriting to GTM workflows confuses some users expecting a simple writing tool.
  • ChatGPT comparison. Many users think "why pay $49/month when ChatGPT does writing for $20?" You need to sell the workflow automation angle.
  • Free tier is very limited. 2,000 words/month is barely enough to test. Some users bounce before seeing real value.

Comments (0)

No comments yet.